Quantcast
Channel: The Cheat Sheet
Browsing latest articles
Browse All 7 View Live

True Religion, Lorillard, United Rentals, Alexion Pharma Stock Analyst Alerts...

True Religion Apparel Inc.(NASDAQ:TRLG): Needham believes the sell-off in True Religion shares from the Q4 miss and conservative guidance is a buying opportunity. The firm believes True Religion is...

View Article



CBS Reiterated at Buy and 3 Reiterated Ratings to Notice Now

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on September 24th. Alexion Pharma (NASDAQ:ALXN): Canaccord Genuity reiterated its rating of Buy...

View Article

Vivus Initiated at Buy and 3 Analyst-Initiated Shares to Watch

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on September 24th. Alexion Pharma (NASDAQ:ALXN): Canaccord Genuity initiated coverage of this company...

View Article

Image may be NSFW.
Clik here to view.

Jim Cramer: Buy Akamai, Alexion Pharma, and These 2 Stocks

Jim Cramer made the following calls on April 1st, 2013. What do you think about his picks? Akamai Technologies Inc. (NASDAQ:AKAM): Jim Cramer ranked this stock a Buy. Cramer previously ranked this...

View Article

Image may be NSFW.
Clik here to view.

3 Merger and Acquisitions Stock Stories to Check Out on Friday

Alamos Gold Inc. (NYSE:AGI): Current price $12.97 Alamos and Esperanza Resources Corp. have reached a definitive agreement that will allow Alamos to purchase the entirety of the issued and outstanding...

View Article


Image may be NSFW.
Clik here to view.

4 Healthcare Stock Stories Making Tuesday Tidings

Mylan Inc. (NASDAQ: MYL): Closing price $32.09 On Tuesday, Mylan announced that Judge Katherine Forrest of the United States District Court for the Southern District of New York has dismissed Teva’s...

View Article

Image may be NSFW.
Clik here to view.

4 Healthcare Stock Stories Making a Buzz On Friday

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA): Closing price $38.34 Analyst Chris Schott at JPMorgan downgraded Teva from Overweight to Neutral and lowered the December 2014 price target from $45...

View Article
Browsing latest articles
Browse All 7 View Live




Latest Images